San Francisco, CANCT04077762Now EnrollingIRB Ready

Patient Satisfaction Clinical Trial in San Francisco, CA

Access cutting-edge patient satisfaction treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Minneapolis Heart Institute Foundation

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access patient satisfaction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related patient satisfaction treatment provided free

Apply for This San Francisco Location

Check if you qualify for this patient satisfaction clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Patient Satisfaction Study in San Francisco

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial infarction undergoing cardiac catheterization. Subjects will be randomized 1:1 into 2 treatment groups: radial access and state-of-the-art femoral access. Randomization will be performed in blocks of 50 per site. Similarly, a second sub-randomization will be performed in the femoral access group into use of 18 vs 21 gauge needles, also in a 1:1 fashion.

Sponsor: Minneapolis Heart Institute Foundation

Who Can Participate

Inclusion Criteria

Age 18 years and older
Undergoing diagnostic angiography for ischemic symptoms with possible PCI, or undergoing planned urgent or elective PCI
Has provided informed consent and agrees to participate
Patients must be equally eligible to undergo cardiac catheterization via radial or femoral access

Exclusion Criteria

Primary PCI for STEMI
Planned right heart catheterization
Valvular heart disease requiring valve surgery within 30 days after the index procedure
Hemodialysis access (arteriovenous fistula or graft) in the arm to be used for PCI in case of assignment to radial approach (the opposite arm may be used for radial access if a dialysis graft is present in one)
Peripheral arterial disease prohibiting vascular access
Presence of bilateral internal mammary artery coronary bypass grafts
International normalized ratio ≥1.5 while treated with oral vitamin K antagonists (i.e. warfarin) Receipt of oral factor Xa or IIa inhibitors ≤24 h before procedure
Planned staged PCI within 30 days after index procedure.
Any planned surgeries within 30 days after index procedure
Planned dual arterial access (for example for chronic total occlusion PCI)
Coexisting conditions that limit life expectancy to less than 30 days
Positive pregnancy test

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT04077762) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Patient Satisfaction Treatment Options in San Francisco, CA

If you're searching for patient satisfaction treatment options in San Francisco, CA, this clinical trial (NCT04077762) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced patient satisfaction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all patient satisfaction clinical trials near you to find additional studies recruiting in your area.

More Fanconi Anemia Trials in San Francisco, CA

See all fanconi anemia clinical trials recruiting in San Francisco — not just this study.

Browse Fanconi Anemia Trials in San Francisco

Browse More Trials by Condition

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA